XML 123 R109.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value of Financial Instruments - Valuation for Level 3 Liabilities (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Total gains (realized/unrealized)      
Sales   $ 77,127,000 $ 17,478,375,000
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Total non-interest (loss) income Total non-interest (loss) income Total non-interest (loss) income
VIE, Primary Beneficiary      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Balance at beginning of period   $ 1,054,335,000 $ 17,777,280,000
Total gains (realized/unrealized)      
Included in earnings     103,782,000
Paydowns     (236,860,000)
Sales     (16,589,867,000)
Balance at the end of period     1,054,335,000
VIE, Primary Beneficiary | Consolidated K-Series      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Balance at beginning of period   0 16,724,451,000
Total gains (realized/unrealized)      
Included in earnings     35,018,000
Paydowns     (147,376,000)
Sales     (16,612,093,000)
Balance at the end of period     0
VIE, Primary Beneficiary | Consolidated SLST      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Balance at beginning of period $ 839,419,000 1,054,335,000 1,052,829,000
Total gains (realized/unrealized)      
Included in earnings (90,077,000) (54,154,000) 68,764,000
Paydowns (114,847,000) (160,762,000) (89,484,000)
Sales     22,226,000
Balance at the end of period $ 634,495,000 $ 839,419,000 $ 1,054,335,000